JAK Inhibitor Succeeds in Refractory Vasculitis
(MedPage Today) -- Patients with treatment-resistant granulomatosis with polyangiitis (GPA) may see improvement with tofacitinib (Xeljanz), results of a small trial suggested.
Among 11 patients for whom at least four previous drugs had failed...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news
More News: Rheumatology | Vasculitis